Exercise Your Blues Away

FRIDAY, Aug. 16, 2019 — Exercise is good medicine for depression, researchers report. “The evidence of the use of physical activity and exercise for the management of depression is substantial and growing fast,” said study authors Felipe Barretto Schuch, from Federal University of Santa Maria in Brazil, and Brendon Stubbs, from King’s College London. “Despite […]

Continue Reading

FDA Approves Inrebic Capsules for Myelofibrosis

FRIDAY, Aug. 16, 2019 — Inrebic (fedratinib) capsules have been approved to treat adults with intermediate-2 or high-risk primary or secondary myelofibrosis, making it the second drug approved to treat patients with this disease, the U.S. Food and Drug Administration announced today. Approval of Inrebic for patients with intermediate-2 or high-risk primary or secondary (post-polycythemia […]

Continue Reading

A Fatty Meal Might Affect How You Absorb CBD

FRIDAY, Aug. 16, 2019 — Having a cheeseburger with that CBD-infused product? A new study suggests that fatty foods might boost the body’s absorption of cannabidiol (CBD). In 2018, CBD capsules received U.S. Food and Drug Administration approval for use in patients with seizures, but how food affects absorption of the drug has been unclear. […]

Continue Reading

Is Dairy Fat Different?

FRIDAY, Aug. 16, 2019 — Dairy foods have been getting a lot of attention from researchers in recent years, notably from studies done both jointly and separately by scientists at Harvard and Tufts universities. They looked at the relationship…

Continue Reading

Roche’s first FDA-approved tumour-agnostic medicine

Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has approved Rozlytrek™ (entrectinib) for the treatment of adults with ROS1-positive, metastatic non-small cell lung cancer (NSCLC). The FDA has also granted accelerated approval to Rozlytrek for the treatment of adult and paediatric patients 12 years of age and […]

Continue Reading